Ruggeri B A, Klurfeld D M, Kritchevsky D, Furlanetto R W
Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania 19104.
Cancer Res. 1989 Aug 1;49(15):4135-41.
Caloric restriction (CR) inhibits tumorigenesis in rodents. To understand the basis for this effect the binding of insulin, insulin-like growth factor I/somatomedin C (IGF-I/Sm-C), insulin-like growth factor II/multiplication stimulating activity (IGF-II/MSA), and epidermal growth factor were examined to membrane preparations of 7,12-dimethylbenz(a)anthracene-induced mammary adenocarcinomas and several normal tissues from female Sprague-Dawley rats. Animals were fed ad libitum (AL) or 25% and 40% calorically restricted diets. Large, palpable (LP) and small, less than or equal to 100 mg, nonpalpable (SNP) tumors were evaluated. Growth factor binding to tumors was differentially affected by CR. IGF-I/Sm-C binding was comparable for AL-LP, AL-SNP, and 25% CR-LP tumors, but elevated in 25% CR-SNP tumors. Scatchard analysis revealed high and low affinity IGF-I/Sm-C binding sites, with AL-SNP and 25% CR-SNP tumors exhibiting similar levels of high affinity sites and at a greater concentration than AL-LP and 25% CR-LP tumors. Insulin binding to mammary tumors was low, i.e., 8- to 13-fold lower than IGF-I/Sm-C binding. The 25% CR-LP and SNP tumors bound 2- to 5-fold more insulin than corresponding AL-LP and SNP tumors. Binding of IGF-II/MSA to these tumor preparations was high, approximately 11- to 25-fold greater than insulin binding, and was unaffected by CR or tumor size. The binding of epidermal growth factor was not detected in any tumor preparations. Receptor binding studies were confirmed with covalent cross-linking and sodium dodecyl sulfate-polyacrylamide gel electrophoresis analyses. Normal tissues exhibited tissue- and growth factor-specific alterations in binding with host CR. Thus, alterations in growth factor binding were not tumor specific, but were less pronounced than in mammary tumors. These findings suggest alterations in IGF-I/Sm-C and insulin binding properties to tumors in relation to CR and tumor size may contribute, in part, to the inhibitory effects of CR on tumorigenesis.
热量限制(CR)可抑制啮齿动物的肿瘤发生。为了解这种作用的基础,研究人员检测了胰岛素、胰岛素样生长因子I/生长调节素C(IGF-I/Sm-C)、胰岛素样生长因子II/促有丝分裂活性因子(IGF-II/MSA)和表皮生长因子与7,12-二甲基苯并(a)蒽诱导的雌性Sprague-Dawley大鼠乳腺腺癌及几种正常组织的膜制剂的结合情况。动物被随意喂食(AL)或给予热量限制25%和40%的饮食。对大的、可触及的(LP)以及小的、小于或等于100毫克的、不可触及的(SNP)肿瘤进行了评估。热量限制对肿瘤的生长因子结合有不同影响。IGF-I/Sm-C与AL-LP、AL-SNP和25% CR-LP肿瘤的结合相当,但在25% CR-SNP肿瘤中升高。Scatchard分析显示存在高亲和力和低亲和力的IGF-I/Sm-C结合位点,AL-SNP和25% CR-SNP肿瘤表现出相似水平的高亲和力位点,且浓度高于AL-LP和25% CR-LP肿瘤。胰岛素与乳腺肿瘤的结合较低,即比IGF-I/Sm-C结合低8至13倍。25% CR-LP和SNP肿瘤比相应的AL-LP和SNP肿瘤多结合2至5倍的胰岛素。IGF-II/MSA与这些肿瘤制剂的结合较高,约比胰岛素结合高11至25倍,且不受热量限制或肿瘤大小的影响。在任何肿瘤制剂中均未检测到表皮生长因子的结合。通过共价交联和十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析证实了受体结合研究。正常组织在宿主热量限制时表现出与组织和生长因子特异性相关的结合改变。因此,生长因子结合的改变并非肿瘤特异性的,但比乳腺肿瘤中的改变不那么明显。这些发现表明,与热量限制和肿瘤大小相关的IGF-I/Sm-C和胰岛素与肿瘤结合特性的改变可能部分有助于热量限制对肿瘤发生的抑制作用。